Aezea® (Cenersen) and Chemotherapy for AML Subjects ≥ 55 Years of Age With No Response to Frontline Induction Course

NCT00967512 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Study Was Terminated due to lack of Funding.

Conditions

Acute Myelogenous Leukemia

Interventions

DRUG: cenersen
DRUG: placebo
DRUG: idarubicin, cytarabine

Sponsor

Eleos, Inc.